BioSpace News Archive

University of Kansas Health System Cardiologist Ashley Simmons knew there could and should be a better way to measure female heart function.

Abbott (NYSE: ABT) today announced the U.S. launch of NeuroSphere™ Virtual Clinic, a first-of-its-kind technology that allows patients to communicate with physicians, ensure proper settings and functionality, and receive new treatment settings remotely as needed

Foldax®, Inc. announced that it has been named by Fierce Medtech as one of the 2020 “Fierce 15,” designating it as one of the most promising private companies in the medical technology industry.

Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Mercy, one of the nation’s most highly integrated, multi-state health care systems, today announced a definitive agreement for Quest to acquire the outreach laboratory services business of Mercy in an all-cash asset transaction

Co-Diagnostics, Inc. (NASDAQ-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Company CEO Dwight Egan will present at the 2021 H.C. Wainwright & Co. Global Life Sciences Conference,

Avail Medsystems, a medical technology company that is pioneering telemedicine for the procedure room, announced that it has been named by Fierce Medtech as one of 2020’s Fierce 15, designating it as one of the most promising private companies in the industry.

Hyperfine Research has been named by Fierce Medtech as one of 2020’s Fierce 15, designating it as one of the most innovative and creative private companies in the industry with its category-defining Swoop™ Portable MR Imaging System.

Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest line of COVID 19 tests. Global WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer is capable of detecting all the current identified SARS-CoV-2 viruses.

On Feb. 26th, 2021, Hongkong Winhealth Pharma Group Co., Ltd (hereinafter referred to as “Winhealth Pharma”) signed a strategic cooperation agreement with Merz Pharmaceuticals GmbH (hereinafter referred to as “Merz”).